Effects of a Combination of Polyphenol-rich Extracts, Prebiotics, and Hydrolyzed Fiber on the Quality of Life of Patients With Irritable Bowel Syndrome (IBS) - Trial NCT05990764
Access comprehensive clinical trial information for NCT05990764 through Pure Global AI's free database. This phase not specified trial is sponsored by AronPharma Sp. z o. o. and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Probiotic, Prebiotic, Polyphenol-rich Extracts
Interventional
dietary supplement
Sponsor & Location
AronPharma Sp. z o. o.
Timeline & Enrollment
N/A
May 08, 2023
Sep 30, 2023
Primary Outcome
IBS-QoL (Irritable Bowel Syndrome-Quality of Life) index,Stool consistency
Summary
The aim of the study is to demonstrate a beneficial effect in reducing symptoms that
 negatively affect the quality of life of IBS patients, and to demonstrate a positive effect
 on inflammatory and intestinal function markers.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05990764
Non-Device Trial